University of Washington spinout AltPep, which is developing tests and treatments for Alzheimer’s and Parkinson’s disease, completed a $52.9 million Series B funding round. The funding will help propel the… Read More
A team of students from the University of Washington is among the global finalists in Microsoft’s annual Imagine Cup after putting their imaginations — and technical skills — to work… Read More
Seattle-based biotech firm Impel NeuroPharma closed its latest round of funding, bringing in $67.5 million to develop treatments for central nervous system disorders, such as migraines and Parkinson’s. This is… Read More